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The Effect of Phenobarbital on Serum Bilirubin
of Full Term Infants
A Controlled

Study

Mary J . Kokosky, M.D.,* Harold A. Falconer, M.D.**
and Lester Weiss, M.D.***

Three bundled twenty-eight infants weighing more than 2500 grams were studied
for the effect of low dose phenobarbital (15 mg/day) upon third and fifth day
serum bdirubin levels. The groups were divided according to sex, race and type
of treatmeiu. Controls were made for the possible effect of the 14% ethanol
contained in phenobarbital elixir. It was found that males had higher mean serum
bilirubin levels than females, Caucasians had higher mean serum bdirubin levels
than Negroes, and control infants had higher serum bilirubin values than those
infants treated with phenobarbital. However, in those patients who had lower
serum bdirubin levels without treatment (Negro females), phenobarbital had little
effect, whde in the group which had high serum bilirubin levels (Caucasian males)
phenobarbital was very effective in reducing the serum bdirubin. The results of the
study suggest that differences of race and sex may have had an effect upon discrepancies in previous studies. Variations between the maturity of the glucuronyl
transferase system in males and females and in Caucasians and Negroes are
suggested by our findings. No immediate side effects of treatment of newborn
infants with phenobarbital were observed.

phenobarbital. In 1964 Burns- reviewed the effect of several drugs, including
phenobarbital, upon microsomal activity in the liver. These drugs were
found to stimulate the metabolism and
clearance of other compounds which
had been administered. Crigler and
Gold'^ and YafTe et al* were able to
demonstrate reduction of serum bilirubin by phenobarbital in patients with
the Crigler-Najar syndrome. Catz and
Yaffe^' demonstrated an increased glucuronyl transferase activity and increased bile flow in young and adult
rabbits treated with phenobarbital. In

The discovery that phenobarbital can
enhance the glucuronidation of bilirubin in the liver of experimental animals
has led to widespread speculation regarding its value in treatment and prevention of neonatal hyperbilirubinemia.
Catz and Yaffe^ in 1962 demonstrated increased conjugation of bilirubin in newborn mice treated with
* Presently at Los Angeles County-University of Southern California Medical Center Newborn Service, Los Angeles
** Presently at Department of Pediatrics,
Albany Medical Center Hospital, A l bany, N . Y.
***Department of Pediatrics
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phenobarbital upon serum bilirubin
levels.
In an attempt to clarify some of the
conflicting results in previous reports,
a study was designed to evaluate the
effect of low dose phenobarbital (15
mg/day) upon the third and fifth day
serum bilirubin levels with controls for
sex and race as well as controls for the
possible effect of ethanol.

1968 Trolle"- ^ discovered that infants
of mothers treated with phenobarbital
and infants treated after birth with
phenobarbital had a lower incidence
of hyperbilirubinemia.
Yeung and Field** studied 210
Chinese newborns with clinical jaundice. Ninety-three were treated with
phenobarbital and 117 were controls.
Exchange transfusion was necessary in
4 of the treated patients and 53 of
the controls. Of significance in their
study was the large number of exchange transfusions required in patients
with idiopathic jaundice. This supported their theory that Chinese babies
have a higher incidence of idiopathic
hyperbilirubinemia than do Caucasians,
presumably on the basis of immature
liver function. Work by Khanna et al"
demonstrated that phenobarbital did
not compete with bilirubin for albumin
binding sites. Cunningham et aP" and
Ramboer et a l " were unable to demonstrate significant reduction of serum
bilirubin levels in neonates treated with
phenobarbital. Furthermore, Levin et
al^- were unable to demonstrate a
statistically significant effect of phenobarbital in infants in whom treatment
was begun after clinical icterus was
present.

Methods and Materials
A double blind study was designed
in which the effect of phenobarbital
upon serum bilirubin levels could be
evaluated in groups which were homogenous with regard to race and sex. It
was necessary to have a double blind
study in order to evaluate the possible
side effects of treatment.
Infants admitted to the newborn
nursery between December 1969 and
May 1970 and who weighed 2500
grams or more were placed into one
of four groups. The four groups were:
Negro males, Negro females, Caucasian
males and Caucasian females. Infants
of oriental, Indian or other racial origins were not included in the study.
Each group was further divided into
two subgroups. Alternate infants were
assigned to each subgroup. One received elixir of phenobarbital (15 mg/
5 cc in 14% ethanol) at a dose of 5
mg every 8 hours. The other, the control group, received an equal volume
of 14% ethanol identical in appearance to the elixir of phenobarbital.
The medications were labelled with
code letters and neither nursery personnel nor the medical staff knew which
was the phenobarbital and which was
the alcohol. A l l medications were administered orally beginning not earlier
than two nor later than ten hours after

In December 1969, Waltman et a l "
reported that ethanol administered to
the mothers before delivery would reduce the serum bilirubin levels in newborn infants but statistically significant
results were achieved only in those
patients who received ethanol in intoxicating doses. No adverse effects
were noted upon the newborn infants,
but no mention was made regarding
testing for hypoglycemia. This study
raises the question of the effect of the
low dose of ethanol present in elixir of
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birth. Treatment was continued for
five consecutive days for a total of 15
doses.
Serum bilirubin levels were determined by the micro-method of de La
Heurga and Sherrick^* on blood obtained from the heel of each infant on
the third and fifth day of life. Duplicate
determinations were performed on each
specimen. ABO blood groups, Rh factor, serology, and direct Coombs' tests
were performed on each infant. The
nursery personnel were instructed to
report somnolence, irritability or poor
feeding if they occurred in any infant
on the study protocol. Daily weights
were recorded on every infant in order
to assess more subtle effects of phenobarbital or ethanol upon feeding. No
infants in the study received phototherapy.
Two infants were excluded from this
study because they failed to receive
the appropriate medication within the
prescribed first ten hours after birth.

One baby was excluded from the study
because of respiratory distress at birth.
Two babies were removed from the
study because of the Rh hemolytic
disease requiring exchange transfusions
within the first 10 hours of life; one
was in the control group and the other
was in the treatment group.
After the study was begun, a second
control group was introduced for the
possible effects of alcohol. The regimen
for this group consisted of water similarly colored. This control was limited
to Negro males and females.
Results
A total of 328 infants was included
in the study; 139 were treated with
phenobarbital elixir, 136 with the control mixture containing 14% ethanol,
and 53, all Negroes, were treated with
water. Table I shows the number of
patients in each group and the mean
and range of the serum bilirubin values
on the cord blood on the third and

TABLE I
SERUM BILIRUBIN LEVELS
GROUP

TREATMENT

NUMBER

SERUM BILIRUBIN (mq %)
CORD

FIFTH DAY

Range

Mean

Range

Mean

Range

Negro
Males

Phenobarbital
Ethanol
Water

39
37
28

L61
L60
L86

0.2-2.8
0.2-3.6
0.9-4.7

5.72
7.27
7.90

0.3-13.0
L 1-14.5
L 1-15.8

3.92
6.58
6.78

0.6-12.0
0.8-15.0
1.2-15.4

Negro
Females

Phenobarbital
Ethanol
Water

34
39
25

L53
L57
L72

0.1-3.0
0.3-2.9
0.4-4.0

5.95
5.91
6.07

0.1-13.7
0.3-17.0
0.5-n.5

3.91
4.81
4.90

0.7-12.5
0.4-20.4
0.4-n.5

Caucasian
Males

Phenobarbital
Ethanol

35
31

L78
L82

0.6-3.5
0.5-3.0

7.18
9.42

L 7-15.0
0.3-18.0

5.73
8.60

0.5-15.9
L 0-16.2

Caucasian
Females

Phenobarbital
Ethanol

31
39

1.45
1.44

0.2-3.5
0.2-3.0

6.65
7.70

0.6-13.1
L 2-16.5

4.45
6.91

0.5-17.5
0.6-18.5
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sary to analyze the data from each
group independently.
Table I I demonstrates the difference
between the mean serum bilirubin
values in the phenobarbital-treated
group and the ethanol control group.
The data obtained were analyzed using
the Student's t-test. The mean serum
bilirubin level in Caucasian males was
lower in the treated group than in the
controls (P <.005) on both days three
and five. A less marked reduction was
observed in Negro males (P <.05 on
day three and P <.005 on day five).
Caucasian females had even less reduction in mean serum bilirubin. The
difference between the control and experimental group on day three was not
significantly different (P >.10). There
was a significant difference on day five
(P <.025). No significant difference
was noted in mean serum bilirubin
levels between the treatment and control group among the Negro females
either on day three or day five.

fifth days. There was no significant
difference between the cord blood bilirubin values from the infants in the
control and the phenobarbital treated
groups.
No patients in the study had sepsis
or congenital syphilis. Two babies had
positive direct Coombs' tests. One, a
Negro male in the group given phenobarbital, was B-Rh positive with his
mother O-Rh positive. The second infant, a Negro female, was also in the
phenobarbital-treated group. She was
O-Rh positive and her mother O-Rh
negative. In neither instance did the
third or fifth day serum bilirubin level
exceed 10 mg %.
No significant difference was found
in the mean serum bilirubin values
between the alcohol- and water-treated
infants. Therefore, the small amount
of alcohol in elixir of phenobarbital is
not sufficient to affect the serum bilirubin level.
Because the mean serum bilirubin
level on days three and five differed
according to race and sex, it was neces-

Table I I I demonstrates the difference
between mean serum bilirubin levels in

TABLE II
EFFECT OF PHENOBARBITAL SERUM BILIRUBIN
GROUP

THIRD DAY
MEAN DIFFERENCE "(mq %)

FIFTH DAY
P value

MEAN DIFFERENCE '(mq %)

P value

Caucasian
Males

2.24

< .005

2.87

< .005

Caucasian
Females

1.05

> .10

2.46

< .025

Negro
Males

1.55

< .05

2.66

< .005

-0.04

"N.S.

0.90

> .10

Negro
Females

" Mean bilirubin values in controls minus mean bilirubin values in phenobarbital treated infants
Not significant
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TABLE III
EFFECT OF RACE ON SERUM BILIRUBI
GROUP

THIRD DAY
MEAN DIFFERENCE "(mq %)

FIFTH DAY
P value

MEAN DIFFERENCE '(mq %)

Rvalue

Control
Males

2.15

<.005

2.02

< .025

Treated
Males

1.46

< .05

1.81

<.05

Control
Females

1.79

< .05

2.10

<.025

Treated
Females

0.70

'"N.S.

0.54

"N.S.

Mean bilirubin values in Caucasians minus the mean bilirubin values in Negroes.
Not significant.

Negroes and Caucasians with the other
two factors constant. The greatest difference between Negroes and Caucasians was evident in the male control
group. The control females had the
next greatest difference. The difference
was even less in the males who were
treated with phenobarbital and there
was no significant difference between
Caucasian and Negro females who
were treated with phenobarbital.

Table IV demonstrates the difference between mean serum bilirubin
levels in males and females, with the
other two factors constant. Here the
differences are less clear. In the Caucasian control group males have higher
serum bilirubin values than females.
On day three the difference is significant (P <0.05). On day five the P
value was between .05 and .10. Similar
results were noted in the Negro control

TABLE IV
EFFECT OF SEX ON SERUM BILIRUBI
GROUP

THIRD DAY
MEAN DIFFERENCE "(mq %)

FIFTH DAY
Rvalue

MEAN DIFFERENCE "(mq %)

Rvalue

Caucasian
Controls

1.72

<.05

1.69

< . 10

Caucasian
Treated

0.53

"N.S.

1.28

>.10

Negro
Controls

1.36

<.10

1.77

<.05

Negro
Treated

0.23

"N.S.

0.01

"N.S.

'" Mean bilirubin values in Males minus the mean bilirubin values in Females.
Not significant.
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group. Again the males had higher
bilirubin levels than the females. On
day three the P value was between
0.05 and 0.10. On day five the P value
was less than 0.05. In both the Caucasian and Negro groups who received
phenobarbital there was no significant
difference in mean serum bilirubin
levels between the sexes.
No immediate side effects were observed in the infants in our study. The
nursery personnel noted no failure to
take feedings, excessive sleepiness, or
irritability during the course of the
study in either the control or treatment
groups. The mean weight loss during
the first five days of life was between
60-70 grams in each of the treatment
groups (water, ethanol and phenobarbital).

lowest serum bilirubin levels when untreated, had the least effect when
treated. Previous studies, which have
sought to delineate the effectiveness of
phenobarbital treatment in reducing
serum bilirubin levels, have failed to
control for sex and racial differences.
In the highly-selected population
studied by Yeung and Field,** (and if
their assumption that Chinese infants
have a poorer functioning glucuronyl
transferase system than Caucasians is
correct), it is not surprising that their
results so strikingly demonstrated the
effectiveness of phenobarbital. Further
confirmation of racial differences in
serum bilirubin levels can be seen in
the study of premature infants by
Hodgman and Schwartz^'' in which the
effects of phototherapy were being
evaluated. Racial differences between
serum bilirubin levels in untreated control infants corresponded closely to
those obtained in our study. Therefore,
it is not unreasonable to hypothesize
that the glucuronyl transferase system
is more mature in Negroes than in
Caucasians, in premature as well as
full-term infants. By the same token the
tendency of male newborns to have
higher serum bilirubin levels than females (which is strongly suggested by
our data) may be an indication that
the glucuronyl transferase enzyme system is less mature in males than in females during the neonatal period. It is
possible that the difference in race and
sex which we observed could be accounted for by the fact that at a given
gestational age, Caucasian newborns
are heavier than Negroes and males
are heavier than females. Since the
weight of 2500 grams or more was
necessary for inclusion in our study,
it is possible that the groups were

Discussion
From our study it is clear that the
variables of race and sex, as well as
phenobarbital treatment, affect serum
bilirubin levels. This may account for
some of the discrepancies among previous studies which have not taken the
factors of race and sex into consideration. If we combine all our data ignoring the variables of race and sex, it
would appear that treatment with
phenobarbital is successful in reducing
mean third and fifth day serum bilirubin levels in a generally healthy
newborn population by about 1.2 and
2.0 mg % respectively. This difference
is statistically significant (P <0.01 on
day three and P <0.0005 on day five).
However, by controlling race and sex
we found that Caucasian males, who
had the highest serum bilirubin levels
when untreated, had the greatest reduction with phenobarbital treatment,
while Negro females, who had the
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not homogenous as to gestational age;
for example the Caucasian male may
have a lower average gestational age
than Negro females. As expected, the
average birth weight of Caucasian
males exceeded that of Negro females
by 300 grams in our study and only
three of our Caucasian males had birth
weights in the range of 2500-2800
grams. That this selection would account for the rather large differences
in our data between Negroes and
Caucasians and between males and
females therefore seems unlikely.
We cannot conclude from this study
that therapy with phenobarbital will
not aid Negro females with potential
hyperbilirubinemia, since the mean
serum bilirubin values in all our groups
were well below the hyperbilirubinemic
level. In spite of the difference of race
and sex that was observed in our study,
it should be emphasized that at the
end of the treatment period infants
who received phenobarbital had lower
mean serum bilirubin levels than their
control counterparts. This is consistent
with results which were recently reported by Stern et aP"^ who found that
phenobarbital treated infants reached
their peak serum bilirubin levels on
the second day of life, as opposed to
a peak on the fourth day of life in
the control infants. Therefore, it is
possible that if the Negro female infants
were subjected to a high serum bilirubin level (as might occur in hemolytic

disease because of ABO incompatibility), phenobarbital may be effective
in promoting more rapid conjugation of
indirect bilirubin. On the other hand,
one could speculate that the glucuronyl
transferase system in the liver of a
mature Negro female infant is already
functioning at maximum capacity and
may be less influenced by enzymeinducing drugs. Further studies in
which controls are made for race and
sex seem desirable in infants susceptible to hyperbilirubinemia.
In a review in June 1970, Behrman
and Fisher" cautioned against routine
use of phenobarbital in high-risk infants until more is known about the
consequences of treatment with a drug
which can cause central nervous system depression and which probably
stimulates many other microsomal enzymes in addition to glucuronyl transferase. No immediate side effects were
demonstrated in the infants in our
studies. Long-term side affects remain
to be assessed and plans are presently
underway to re-evaluate the infants in
this study at yearly intervals.
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